Skip to content
No picture yet

Ninlaro 2.3 mg – DIN 02456796

Ninlaro is Ixazomib Citrate 2.3 mg (capsule), sold in Canada. It is used for multiple myeloma. It is supplied by Takeda Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Ixazomib Citrate 2.3 mg

Brand
Ninlaro
Strength
2.3 mg
Used for
Multiple myeloma
Form
Capsule
Manufacturer
Takeda Canada Inc
Drug class
Proteasome inhibitor
Sold in
Canada
DIN
02456796

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ixazomib pills and guides

What is Ixazomib used for?

Ixazomib is used for multiple myeloma.

Medicine type
Proteasome inhibitor
Official uses from the US prescribing label

NINLARO® is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Limitations of Use: NINLARO is not recommended for use in the maintenance setting or in newly diagnosed multiple myeloma in combination with lenalidomide and dexamethasone outside of controlled clinical trials.

From the FDA-approved label on DailyMed (published Aug 17, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02456796.
  • It names Ninlaro, Ixazomib Citrate 2.3 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Ninlaro by Takeda Canada Inc.

In Canada: prescription only.

Ingredients

Active: Ixazomib (Ixazomib Citrate)

Other Ixazomib pills